# IMPRIMIS PHARMACEUTICALS INC (IMMY)

> Institutional ownership reported to the SEC as of Q1 2020, from Form 13F filings. Source: https://holderbook.com/stocks/IMMY/

- Reporting holders: 1
- Reported value: $9.6M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Opaleye Management Inc.](https://holderbook.com/funds/1595855-opaleye-management-inc/) | $9.6M | 2,500,000 | 2.5% | 6 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2020 | 1 | $9.6M |
| Q4 2019 | 1 | $18.2M |
| Q3 2019 | 1 | $13.3M |
| Q2 2019 | 1 | $19.2M |
| Q1 2019 | 1 | $9.0M |
| Q4 2018 | 42 | $31.1M |